LizarBio Therapeutics
PrivateTotal Funding Raised
$2.18M
Company Overview
LizarBio Therapeutics is a biotechnology company that develops cell therapies using cardiomyocyte grafts for the treatment of cardiovascular diseases and other incurable conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LizarBio Therapeutics Comparables
Compare LizarBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avery Therapeutics, Inc. | 85% | |
| IPS HEART | 84% | |
| Cuorips Inc. | 78% |
LizarBio Therapeutics Funding Rounds
Historical fundraising activity
LizarBio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libbs Ventures | Corporate Funding |
| FAPESP | Grant |
LizarBio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LizarBio Therapeutics's valuation, stock price, and market status.
Is LizarBio Therapeutics a public or private company?
LizarBio Therapeutics is a private company.
What is the current stock price of LizarBio Therapeutics?
LizarBio Therapeutics is a private company with no public stock price. Caplight tracks LizarBio Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is LizarBio Therapeutics worth (valuation)?
Valuation information for LizarBio Therapeutics is not publicly available.
Can I buy LizarBio Therapeutics stock?
LizarBio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LizarBio Therapeutics's last funding round?
Funding round information for LizarBio Therapeutics is not publicly available.
Who are the main investors in LizarBio Therapeutics?
Key investors in LizarBio Therapeutics include Libbs Ventures, FAPESP.
Will LizarBio Therapeutics IPO soon?
No public IPO plans have been announced for LizarBio Therapeutics.
How can I track LizarBio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LizarBio Therapeutics's secondary market activity and sign up for updates.